News related to Nexavar (Sorafenib) and/or conditions it is approved for
Cabozantinib improves progression-free survival in metastatic renal cell carcinoma
Source: Clinical Trials / Drug Trials News From Medical News Today [2016.10.12]
Cabozantinib significantly improves progression-free survival and response rate in patients with metastatic renal cell carcinoma compared to sunitinib, according to research presented at the ESMO...
Longer disease-free survival in phase III trial of sunitinib as adjuvant treatment for kidney cancer
Source: Urology / Nephrology News From Medical News Today [2016.10.10]
A phase III trial of sunitinib has met its primary endpoint of disease-free survival for adjuvant treatment of high-risk renal cell carcinoma after nephrectomy, researchers report at the ESMO 2016...